Lexaria Book Value Per Share from 2010 to 2024

LEXXW Stock

USD 0.80 0.05 6.67%

Lexaria Bioscience Book Value Per Share yearly trend continues to be fairly stable with very little volatility. Book Value Per Share will likely drop to 0.08 in 2024. Book Value Per Share is the ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of Lexaria Bioscience Corp according to its financial statements. View All Fundamentals

Book Value Per Share

First Reported

2010-12-31

Previous Quarter

0.61846472

Current Value

0.08164739

Quarterly Volatility

0.71426497

Credit Downgrade

Yuan Drop

Covid

Check Lexaria Bioscience financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Lexaria Bioscience's main balance sheet or income statement drivers, such as Depreciation And Amortization of 132.7 K, Interest Expense of 125.2 K or Other Operating Expenses of 3.2 M, as well as many indicators such as Price To Sales Ratio of 105, Dividend Yield of 0.0 or PTB Ratio of 54.87. Lexaria financial statements analysis is a perfect complement when working with Lexaria Bioscience Valuation or Volatility modules.

Check out the analysis of Lexaria Bioscience Correlation against competitors.

Latest Lexaria Bioscience's Book Value Per Share Growth Pattern

Below is the plot of the Book Value Per Share of Lexaria Bioscience Corp over the last few years. It is the ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements. Lexaria Bioscience's Book Value Per Share historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Lexaria Bioscience's overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 0.64 X

10 Years Trend

Pretty Stable

Compare to Others All Fundamentals

Book Value Per Share

Timeline

Lexaria Book Value Per Share Regression Statistics

	Arithmetic Mean	0.81
	Geometric Mean	0.56
	Coefficient Of Variation	87.85
	Mean Deviation	0.49
	Median	0.50
	Standard Deviation	0.71
	Sample Variance	0.51
	Range	2.9147
	R-Value	0.21
	Mean Square Error	0.53
	R-Squared	0.04
	Significance	0.46
	Slope	0.03
	Total Sum of Squares	7.14

Lexaria Book Value Per Share History

	2024	0.0816
	2023	0.62
	2022	0.41
	2021	1.3
	2020	2.97
	2019	0.9
	2018	0.96

Other Fundumenentals of Lexaria Bioscience Corp

Tangible Book Value Per Share

Lexaria Bioscience Book Value Per Share component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Total Liab	Total Current Assets	Common Stock	Current Deferred Revenue	Net Receivables	Short Term Debt	Intangible Assets	Long Term Debt	Capital Surpluse	Property Plant Equipment	Net Invested Capital	Net Working Capital	Short Term Investments	Capital Stock	Short Long Term Debt
Total Assets		0.99	-0.9	-0.66	0.51	0.31	0.95	-0.55	-0.54	0.49	-0.19	0.67	-0.57	0.64	0.69	0.82	0.69	0.75	-0.81	-0.49
Total Stockholder Equity	0.99		-0.95	-0.69	0.46	0.16	0.98	-0.51	-0.6	0.46	-0.28	0.7	-0.62	0.68	0.7	0.86	0.73	0.81	-0.83	-0.45
Net Debt	-0.9	-0.95		0.68	-0.43	0.1	-0.99	0.38	0.55	-0.36	0.42	-0.68	0.66	-0.68	-0.67	-0.84	-0.72	-0.79	0.79	0.43
Retained Earnings	-0.66	-0.69	0.68		-0.68	-0.12	-0.71	0.29	0.48	-0.39	0.59	-0.93	0.82	-0.88	-0.91	-0.36	-0.15	-0.34	0.84	0.6
Accounts Payable	0.51	0.46	-0.43	-0.68		0.54	0.5	-0.4	0.07	-0.02	-0.2	0.46	-0.39	0.38	0.54	0.04	-0.19	-0.09	-0.59	-0.94
Total Liab	0.31	0.16	0.1	-0.12	0.54		0.05	-0.44	0.16	0.15	0.39	0.03	0.13	-0.06	0.1	-0.09	-0.19	-0.18	-0.17	-0.47
Total Current Assets	0.95	0.98	-0.99	-0.71	0.5	0.05		-0.45	-0.55	0.41	-0.37	0.7	-0.65	0.68	0.7	0.84	0.7	0.78	-0.82	-0.49
Common Stock	-0.55	-0.51	0.38	0.29	-0.4	-0.44	-0.45		0.59	0.15	-0.32	-0.32	-0.11	-0.08	-0.23	-0.49	-0.41	-0.4	0.72	0.33
Current Deferred Revenue	-0.54	-0.6	0.55	0.48	0.07	0.16	-0.55	0.59		-0.26	0.2	-0.63	0.32	-0.49	-0.46	-0.72	-0.7	-0.77	0.75	-0.13
Net Receivables	0.49	0.46	-0.36	-0.39	-0.02	0.15	0.41	0.15	-0.26		-0.2	0.48	-0.52	0.6	0.53	0.39	0.35	0.47	-0.21	0.02
Short Term Debt	-0.19	-0.28	0.42	0.59	-0.2	0.39	-0.37	-0.32	0.2	-0.2		-0.47	0.6	-0.52	-0.45	-0.18	-0.1	-0.21	0.31	0.19
Intangible Assets	0.67	0.7	-0.68	-0.93	0.46	0.03	0.7	-0.32	-0.63	0.48	-0.47		-0.8	0.96	0.92	0.44	0.3	0.48	-0.82	-0.33
Long Term Debt	-0.57	-0.62	0.66	0.82	-0.39	0.13	-0.65	-0.11	0.32	-0.52	0.6	-0.8		-0.9	-0.78	-0.3	-0.17	-0.35	0.56	0.35
Capital Surpluse	0.64	0.68	-0.68	-0.88	0.38	-0.06	0.68	-0.08	-0.49	0.6	-0.52	0.96	-0.9		0.9	0.4	0.28	0.48	-0.67	-0.27
Property Plant Equipment	0.69	0.7	-0.67	-0.91	0.54	0.1	0.7	-0.23	-0.46	0.53	-0.45	0.92	-0.78	0.9		0.43	0.24	0.44	-0.73	-0.49
Net Invested Capital	0.82	0.86	-0.84	-0.36	0.04	-0.09	0.84	-0.49	-0.72	0.39	-0.18	0.44	-0.3	0.4	0.43		0.96	0.96	-0.65	-0.09
Net Working Capital	0.69	0.73	-0.72	-0.15	-0.19	-0.19	0.7	-0.41	-0.7	0.35	-0.1	0.3	-0.17	0.28	0.24	0.96		0.96	-0.48	0.16
Short Term Investments	0.75	0.81	-0.79	-0.34	-0.09	-0.18	0.78	-0.4	-0.77	0.47	-0.21	0.48	-0.35	0.48	0.44	0.96	0.96		-0.6	0.09
Capital Stock	-0.81	-0.83	0.79	0.84	-0.59	-0.17	-0.82	0.72	0.75	-0.21	0.31	-0.82	0.56	-0.67	-0.73	-0.65	-0.48	-0.6		0.52
Short Long Term Debt	-0.49	-0.45	0.43	0.6	-0.94	-0.47	-0.49	0.33	-0.13	0.02	0.19	-0.33	0.35	-0.27	-0.49	-0.09	0.16	0.09	0.52

Click cells to compare fundamentals

About Lexaria Bioscience Financial Statements

Lexaria Bioscience investors use historical fundamental indicators, such as Lexaria Bioscience's Book Value Per Share, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Lexaria Bioscience. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Book Value Per Share	0.62	0.08
Tangible Book Value Per Share	0.58	0.08

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

Additional Tools for Lexaria Stock Analysis

When running Lexaria Bioscience's price analysis, check to measure Lexaria Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lexaria Bioscience is operating at the current time. Most of Lexaria Bioscience's value examination focuses on studying past and present price action to predict the probability of Lexaria Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lexaria Bioscience's price. Additionally, you may evaluate how the addition of Lexaria Bioscience to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC